Press release
Preclinical Oncology Models Market - Know the Untapped Revenue Growth Opportunities
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Preclinical Oncology Models Market- by Product (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model and Others), Application (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Fibrosarcoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/1093
According to the latest research by InsightAce Analytic, the global Preclinical Oncology Models market will be valued at US$ 1.02 Billion in 2021. It is expected to reach US$ 2.46 Billion by 2030, with a CAGR of 10.6% during a forecast period of 2022-2030.
Preclinical oncology models are necessary for researchers to forecast the clinical effectiveness of potential anticancer drugs. The rising need for cancer immunotherapy has prompted numerous preclinical and translational difficulties, and Preclinical models are crucial for accurately screening anticancer drugs with solid clinical connections.
The market growth is anticipated to be fueled by developments in immuno-oncology, soaring targeted and novel cancer therapies, rising oncology-related R&D activities, high demand for reliable preclinical oncology models like humanized and syngeneic tumor models, and the growing need to reduce translational failures in clinical trials. In addition, the requirement for the logical design of combination medicines and the early identification of predictive biomarkers also contribute to the market expansion for preclinical oncology models. The preclinical cancer models market is expanding due to factors like early identification of predictive biomarkers, harnessing phenotypic aspects of models, and the requirement for rational combination therapy design. The emergence of immuno-oncology therapies such as T cell therapy, bispecific antibodies, immune checkpoint modulators, and tailored cancer vaccines necessitates the development of novel preclinical and translational service solutions. The preclinical oncology models market is fragmented, with many competitors providing services in domestic and global markets.
North America is anticipated to contribute to the Preclinical Oncology Models market because preclinical oncology models are required, cancer research funding is rising, and there is a large demand for cancer immunotherapies. In addition, the Asia Pacific Preclinical Oncology Models market is expected to register significant growth. The regional market expansion drivers include the development of cancer diagnostic and therapeutic technologies, the increased demand for targeted medicines, and the rising R&D activities in oncology clinical trials by industry participants.
Major market players operating in the Preclinical Oncology Models market include
Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc, Pharmatest Services, Taconic Biosciences, Inc., and The Jackson Laboratory.
Recent collaborations and agreements in the market:
• In December 2021, the Crown Bioscience facility in the United Kingdom grew. Crown Bioscience is a top contract research organization (CRO) for preclinical and translational drug development services. This expansion provides more imaging options to help observe and comprehend the course of the tumor and its response to potential treatments. The new imaging platform enables the execution of state-of-the-art preclinical research, providing advanced insights on possible medication candidates before clinical trials.
• In February 2021, Kibur Medical and Charles River Laboratories International, Inc. collaborated to give in vivo preclinical oncology studies exclusive access to their implantable microdevice (IMD).
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1093
Market Segments
Global Preclinical Oncology Models Market, by Product, 2022-2030 (Value US$ Mn)
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
Global Preclinical Oncology Models Market, by Application, 2022-2030 (Value US$ Mn)
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
Global Preclinical Oncology Models Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Preclinical Oncology Models market
To receive an industry overview and future trends of the Preclinical Oncology Models market
To analyze the Preclinical Oncology Models market drivers and challenges
To get information on the Preclinical Oncology Models market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Preclinical Oncology Models market industry
For More Information @ https://www.insightaceanalytic.com/customisation/1093
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Oncology Models Market - Know the Untapped Revenue Growth Opportunities here
News-ID: 3394211 • Views: …
More Releases from InsightAce Analytic Pvt.Ltd
AI In The Credit-Scoring Market Smarter Credit Decisions: How AI is Transforming …
AI In The Credit-Scoring Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI In The Credit-Scoring Market - (By Component (Software and Service), By Application (Personal Credit Scoring and Corporate Credit Scoring), By Industry Vertical (BFSI (Banking, Financial Services, Insurance), Retail, Healthcare,
Telecommunications, Utilities, and Real Estate)), Trends,…
Surgical Robotics Simulation Market Guiding the Next Generation of Surgeons: Gro …
Surgical Robotics Simulation Market Worth $1,283.6 Mn by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Surgical Robotics Simulation Market Size, Share & Trends Analysis Report By Product Type (Product, Services), By Application (General Surgery, Gynecological Surgery, Urological Surgery, Neurological Surgery (Head and Neck Surgery), Cardiological Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers,…
AI Studio Market Accelerating Innovation: The Benefits of AI Studios for Busines …
Global AI Studio Market Worth $57.89 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI Studio Market- (By Application (Sentiment Analysis, Customer Service Automation, Image Classification & Labelling, Synthetic Data Generation, Predictive Modelling & Forecasting, Automatic Content Generation, and Others), By Offering, By Vertical, By Region, Trends, Industry Competition Analysis, Revenue and Forecast…
Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market G …
Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market- (Disease (Neurological Disorders and Dystrophies, Cardiac disorders, Retinal Eye Disease, Metabolic Disorders, Liver disease, Others), Products and Services (Disease Model,
Reprogramming service, Differentiation…
More Releases for Model
Animal Model Market
The Global Animal Model Market, detailed in the TechSci Research report titled, "Animal Model Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028," exhibited a value of USD 1.67 billion in 2022, poised to grow at a Compound Annual Growth Rate (CAGR) of 7.64% from 2024 to 2028. This comprehensive analysis delves into the intricate web of factors driving the market, including the global burden of chronic…
Executing a Business Model Transformation with A Business Model Canvas
Business model transformation is the process of changing the way a company operates, with the aim of improving its overall performance. This transformation often involves significant changes to a company's existing business model. To ensure that the transformation process is successful, companies can use a tool called the business model canvas. Get a free business model canvas here: https://digitalleadership.com/unite-articles/extended-business-model-canvas/
Steps in Executing a Business Model Transformation with A Business Model Canvas
Business…
Fourth Party Logistics Market : Industry Innovator Model, Solution Integrator Mo …
The fourth party logistics market was valued at $57.9 billion in 2021, and is estimated to reach $111.7 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Fourth party logistics, popularly known as 4PL, is the model of outsourcing of logistics operations, where the service provider integrates with the company's supply chain department. This logistics partner is responsible for assessing, designing, building, running, and measuring integrated supply…
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’
Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis
The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is…
